| Literature DB >> 33552309 |
Takaaki Ikeda1,2, Ataru Igarashi3, Satomi Odani4, Masayasu Murakami1, Takahiro Tabuchi4.
Abstract
This cross-sectional study examined the association between job loss during the coronavirus disease 2019 (COVID-19) pandemic and health-related quality of life (HRQOL) in the Japanese working population and whether universal financial support program has a protective influence on the HRQOL. Two self-reported internet surveys were used to determine job loss during the pandemic: one was conducted between February and March 2020, just before the COVID-19 emergency declaration by the Japanese government (April 2020), and the other was conducted between August and September 2020. For the dependent variable, we used the EQ-5D-5L utility score (QOL utility score), which was assessed between August and September 2020. The independent variables were job loss after the state of emergency was declared and two types of government financial support (either universal support or support targeting child-raising households). The Tobit regression model was applied, adjusting for covariates. Job loss during the pandemic was negatively associated with the QOL utility score in the fully adjusted model; the coefficient (95% confidence interval [CI]) for job loss during the pandemic was -0.07 (-0.11 to -0.03). For the government financial support variables, the universal financial support program was associated with a better QOL utility score of the coefficient (95% CI), 0.05 (0.03 to 0.08). Job loss during the COVID-19 pandemic is negatively associated with HRQOL, while universal financial support is positively associated with HRQOL. Our study results imply that universal financial support during the COVID-19 era has a protective influence on an individual's HRQOL. Supplementary Information: The online version contains supplementary material available at 10.1007/s11482-021-09918-6. © The International Society for Quality-of-Life Studies (ISQOLS) and Springer Nature B.V. 2021.Entities:
Keywords: Allowance; EQ-5D; Euro-QoL; SARS-CoV-2; Socioeconomic status; Subsidy
Year: 2021 PMID: 33552309 PMCID: PMC7846494 DOI: 10.1007/s11482-021-09918-6
Source DB: PubMed Journal: Appl Res Qual Life ISSN: 1871-2576
Characteristics before the declaration and quality of life utility score (n = 4177)
| Total number of respondents | Quality of life utility score | |||
|---|---|---|---|---|
| Mean | SD | 25th–75th percentile | ||
| Age group (years) | ||||
| 18–30 | 865 | 0.91 | 0.16 | 0.85–1.00 |
| 31–40 | 858 | 0.92 | 0.13 | 0.87–1.00 |
| 41–46 | 785 | 0.92 | 0.11 | 0.87–1.00 |
| 47–53 | 889 | 0.92 | 0.12 | 0.83–1.00 |
| 54–59 | 780 | 0.92 | 0.10 | 0.87–1.00 |
| Gender | ||||
| Men | 2639 | 0.92 | 0.13 | 0.87–1.00 |
| Women | 1538 | 0.91 | 0.12 | 0.83–1.00 |
| Highest education level (years) | ||||
| ≤9 | 29 | 0.79 | 0.23 | 0.69–1.00 |
| 10–12 | 873 | 0.91 | 0.13 | 0.82–1.00 |
| ≥13 | 3275 | 0.92 | 0.12 | 0.87–1.00 |
| Quintile of income level | ||||
| 1st (lowest) | 903 | 0.88 | 0.16 | 0.82–1.00 |
| 2nd | 809 | 0.92 | 0.12 | 0.87–1.00 |
| 3rd | 801 | 0.92 | 0.12 | 0.87–1.00 |
| 4th | 858 | 0.93 | 0.11 | 0.87–1.00 |
| 5th (highest) | 806 | 0.93 | 0.11 | 0.87–1.00 |
| Occupation | ||||
| Manager | 168 | 0.91 | 0.17 | 0.83–1.00 |
| Permanent | 2814 | 0.92 | 0.12 | 0.87–1.00 |
| Self-owned | 334 | 0.89 | 0.15 | 0.82–1.00 |
| Non-permanent | 835 | 0.90 | 0.12 | 0.83–1.00 |
| Internal | 26 | 0.84 | 0.13 | 0.76–1.00 |
| Hypertension | ||||
| No | 3668 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 509 | 0.88 | 0.16 | 0.82–1.00 |
| Diabetes | ||||
| No | 3652 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 525 | 0.89 | 0.17 | 0.82–1.00 |
| Cancer | ||||
| No | 3771 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 406 | 0.88 | 0.17 | 0.82–1.00 |
| Angina | ||||
| No | 4108 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 69 | 0.78 | 0.25 | 0.85–1.00 |
| Chronic obstructive pulmonary disease | ||||
| No | 3796 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 381 | 0.88 | 0.17 | 0.82–1.00 |
| Bronchitis/pneumonia | ||||
| No | 4061 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 116 | 0.79 | 0.24 | 0.83–1.00 |
| Asthma | ||||
| No | 3959 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 218 | 0.86 | 0.19 | 0.82–1.00 |
| Periodontal disease | ||||
| No | 3733 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 444 | 0.87 | 0.16 | 0.82–1.00 |
| Caries | ||||
| No | 3785 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 392 | 0.87 | 0.16 | 0.82–1.00 |
| Chronic pain | ||||
| No | 4096 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 81 | 0.75 | 0.25 | 0.82–1.00 |
| Psychological disorder other than depression | ||||
| No | 3657 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 520 | 0.86 | 0.17 | 0.81–1.00 |
Depression before the declaration was omitted as none of the respondents answered “yes” to the question
Characteristics after the emergency declaration and quality of life utility score (n = 4177)
| Total number of respondents | Quality of life utility score | |||
|---|---|---|---|---|
| Mean | SD | 25th–75th percentile | ||
| Job loss during the pandemic | ||||
| No | 4031 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 146 | 0.83 | 0.18 | 0.78–1.00 |
| Special Cash Payment | ||||
| Not received | 442 | 0.87 | 0.23 | 0.81–1.00 |
| Received | 3735 | 0.92 | 0.11 | 0.87–1.00 |
| Temporary Special Benefit for Child-raising Households | ||||
| Not received | 3718 | 0.92 | 0.13 | 0.87–1.00 |
| Received | 459 | 0.91 | 0.12 | 0.87–1.00 |
| Onset of hypertension | ||||
| No | 4046 | 0.92 | 0.13 | 0.87–1.00 |
| Yes | 131 | 0.89 | 0.14 | 0.82–1.00 |
| Onset of diabetes | ||||
| No | 4133 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 44 | 0.76 | 0.22 | 0.54–1.00 |
| Onset of cancer | ||||
| No | 4158 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 19 | 0.78 | 0.28 | 0.57–1.00 |
| Onset of angina | ||||
| No | 4153 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 24 | 0.74 | 0.28 | 0.55–1.00 |
| Onset of chronic obstructive pulmonary disease | ||||
| No | 4153 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 24 | 0.78 | 0.23 | 0.56–1.00 |
| Onset of bronchitis/pneumonia | ||||
| No | 4139 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 38 | 0.84 | 0.21 | 0.72–1.00 |
| Onset of periodontal disease | ||||
| No | 3995 | 0.92 | 0.13 | 0.87–1.00 |
| Yes | 182 | 0.89 | 0.13 | 0.82–1.00 |
| Onset of caries | ||||
| No | 3936 | 0.92 | 0.13 | 0.87–1.00 |
| Yes | 241 | 0.89 | 0.13 | 0.82–1.00 |
| Onset of chronic pain | ||||
| No | 3850 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 327 | 0.84 | 0.13 | 0.78–1.00 |
| Onset of depression | ||||
| No | 3976 | 0.92 | 0.12 | 0.87–1.00 |
| Yes | 201 | 0.76 | 0.18 | 0.68–1.00 |
| Onset of psychological disorder other than depression | ||||
| No | 4114 | 0.92 | 0.13 | 0.87–1.00 |
| Yes | 63 | 0.84 | 0.15 | 0.78–1.00 |
Onset of asthma was omitted as none of the respondents answered “yes” to the question
Unemployment status at follow-up and responses to each EQ-5D-5L question (n = 4177)
| 5 level items in each question | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 (no problems) | 2 (slight problems) | 3 (moderate problems) | 4 (severe problems) | 5 (unable to/extreme problems) | ||||||
| N | % | N | % | N | % | N | % | N | % | |
| Mobility | ||||||||||
| Did not experience job loss | 3813 | 94.6 | 144 | 3.6 | 34 | 0.8 | 20 | 0.5 | 20 | 0.5 |
| Experienced job loss | 120 | 82.2 | 11 | 7.5 | 8 | 5.5 | 4 | 2.7 | 3 | 2.1 |
| Self-care | ||||||||||
| Did not experience job loss | 3913 | 97.1 | 60 | 1.5 | 29 | 0.7 | 13 | 0.3 | 16 | 0.4 |
| Experienced job loss | 127 | 87.0 | 7 | 4.8 | 6 | 4.1 | 5 | 3.4 | 1 | 0.7 |
| Usual activities | ||||||||||
| Did not experience job loss | 3811 | 94.5 | 139 | 3.5 | 49 | 1.2 | 13 | 0.3 | 19 | 0.5 |
| Experienced job loss | 118 | 80.8 | 11 | 7.5 | 10 | 6.9 | 4 | 2.7 | 3 | 2.1 |
| Pain/discomfort | ||||||||||
| Did not experience job loss | 2780 | 69.0 | 978 | 24.3 | 201 | 5.0 | 52 | 0.3 | 20 | 0.5 |
| Experienced job loss | 82 | 56.2 | 47 | 32.2 | 11 | 7.5 | 5 | 3.4 | 1 | 0.7 |
| Anxiety/depression | ||||||||||
| Did not experience job loss | 2871 | 71.2 | 803 | 19.9 | 220 | 5.5 | 83 | 2.1 | 54 | 1.3 |
| Experienced job loss | 60 | 41.1 | 54 | 37.0 | 18 | 12.3 | 8 | 5.5 | 6 | 4.1 |
Associations of job loss during the pandemic, characteristics, and government financial support variables with quality of life utility score (n = 4177)
| Model 1 | Model 2 | Model 3 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Coef. | 95% CIs | Coef. | 95% CIs | Coef. | 95% CIs | ||||
| Job loss (ref. no) | |||||||||
| Special Cash Payment (ref. no) | |||||||||
| Temporary Special Benefit for Child-raising Households (ref. no) | −0.001 | −0.03 | 0.03 | 0.00 | −0.02 | 0.03 | 0.00 | −0.02 | 0.03 |
| Age | −0.0002 | −0.001 | 0.001 | 0.0003 | −0.0004 | 0.001 | |||
| Sex (ref. women) | |||||||||
| Occupation (ref. manager) | |||||||||
| Permanent | 0.01 | −0.03 | 0.05 | 0.00 | −0.04 | 0.04 | |||
| Self-employer | −0.04 | −0.09 | 0.01 | −0.03 | −0.08 | 0.02 | |||
| Non-permanent | 0.01 | −0.04 | 0.05 | 0.00 | −0.04 | 0.05 | |||
| Internal | −0.09 | −0.19 | 0.01 | −0.08 | −0.18 | 0.02 | |||
| Education (ref. 13 years) | |||||||||
| 10–12 years | −0.02 | −0.03 | 0.002 | ||||||
| ≤9 years | |||||||||
| Income (ref. highest) | |||||||||
| 4th | −0.02 | −0.05 | 0.005 | −0.02 | −0.04 | 0.01 | |||
| 3rd | −0.02 | −0.05 | 0.006 | −0.02 | −0.05 | 0.00 | |||
| 2nd | −0.02 | −0.05 | 0.004 | −0.02 | −0.05 | 0.01 | |||
| 1st (lowest) | |||||||||
| Insurance type (ref. Employee Health Insurance) | |||||||||
| National Health Insurance | 0.00 | −0.02 | 0.02 | 0.00 | −0.02 | 0.02 | |||
| Diabetes at baseline (ref. no) | −0.01 | −0.05 | 0.02 | −0.02 | −0.06 | 0.02 | |||
| Cancer at baseline (ref. no) | 0.00 | −0.06 | 0.07 | 0.01 | −0.05 | 0.07 | |||
| Psychological disorder other than depression at baseline (ref. no) | |||||||||
| Chronic obstructive pulmonary disease at baseline (ref. no) | 0.09 | 0.02 | 0.15 | 0.06 | −0.01 | 0.12 | |||
| Hypertension at baseline (ref. no) | |||||||||
| Asthma at baseline (ref. no) | 0.00 | −0.04 | 0.04 | 0.00 | −0.04 | 0.04 | |||
| Bronchitis/pneumonia at baseline (ref. no) | |||||||||
| Periodontal disease at baseline (ref. no) | |||||||||
| Caries at baseline (ref. no) | |||||||||
| Angina at baseline (ref. no) | 0.04 | −0.04 | 0.11 | 0.04 | −0.03 | 0.11 | |||
| Chronic pain at baseline (ref. no) | |||||||||
| Changes in income | 0.00005 | −0.00002 | 0.0001 | ||||||
| Onset of Diabetes (ref. no) | −0.07 | −0.15 | 0.00 | ||||||
| Onset of Cancer (ref. no) | 0.06 | −0.07 | 0.19 | ||||||
| Onset of depression (ref. no) | |||||||||
| Onset of psychological disorder other than depression (ref. no) | −0.01 | −0.08 | 0.05 | ||||||
| Onset of chronic obstructive pulmonary disease (ref. no) | 0.05 | −0.07 | 0.16 | ||||||
| Onset of hypertension (ref. no) | |||||||||
| Onset of bronchitis/pneumonia (ref. no) | 0.04 | −0.05 | 0.12 | ||||||
| Onset of periodontal disease (ref. no) | −0.03 | −0.07 | 0.00 | ||||||
| Onset of caries (ref. no) | |||||||||
| Onset of angina (ref. no) | −0.05 | −0.16 | 0.06 | ||||||
| Onset of chronic pain (ref. no) | |||||||||
| Constant | |||||||||
| AIC | – | 2740.92 | 2479.06 | ||||||
| BIC | – | 2924.70 | 2738.89 | ||||||
Coef., coefficient; 95% CIs, 95% confidence intervals; AIC, Akaike information criterion; BIC, Bayesian information criterion
Depression assessed before the declaration and onset of asthma were omitted as none of the respondents answered “yes” to the questions
Statistical significance at P < 0.05 is indicated in bold